US House adopts FDA user fee bill with ease; reconciliation with Senate ahead
This article was originally published in Clinica
Executive Summary
The US House of Representatives on 30 May swiftly adopted its version of the FDA user fee bill in a somewhat anticlimactic 387-5 vote, without the fire-and-brimstoning that came in the Senate. However, the latter chamber, too, easily passed its legislation, 96-1, with very little debate – a rare occurrence in Washington, especially lately (www.clinica.co.uk, 28 May 2012).